Pfizer’s Trumenba Approval To Ignite EU Marketing Battle
Another meningitis vaccine from Pfizer has been cleared for marketing in Europe, completing the company's portfolio and providing competition to GSK’s growing vaccines business.
You may also be interested in...
It's Emma Walmsley's first week at the helm of GlaxoSmithKline. What can we expect in terms of her priorities?
Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.
Laura Soucek, one of In Vivo’s 2020 Rising Leaders, is hoping to take Barcelona-based start-up Peptomyc to the next level. The company is nearing the clinic with an inhibitor of the transcription factor Myc, which is involved in the regulation of cellular proliferation, but can also be a driver of cancer.